In the quest for more effective treatments for Central Nervous System (CNS) disorders, pharmaceutical researchers and developers are constantly seeking advanced chemical intermediates. Diethyl L-Glutamate Hydrochloride (CAS 1118-89-4) has emerged as a pivotal compound, recognized for its significant role in enhancing the efficacy of CNS drugs. As a leading supplier of this crucial pharmaceutical intermediate, we provide a product essential for innovative drug development.

The primary value of Diethyl L-Glutamate Hydrochloride lies in its contribution to drug bioavailability. This means that when used in drug formulations, it helps the active pharmaceutical ingredient to be absorbed more efficiently by the body. This improved absorption is critical for drugs targeting the complex pathways of the brain, ensuring that therapeutic concentrations are achieved and maintained. For conditions like epilepsy, where timely and consistent drug action is vital, this enhanced bioavailability is a game-changer in anticonvulsant drug synthesis.

Our commitment as a manufacturer in China is to provide Diethyl L-Glutamate Hydrochloride with exceptional purity (typically ≥99.0% assay). This high standard is non-negotiable for pharmaceutical applications where even minor impurities can have significant consequences. Researchers involved in laboratory R&D and chemical synthesis can rely on our product as a consistent and high-quality starting material. Whether your focus is on novel anticonvulsant development or broader CNS drug research, our intermediate provides a reliable foundation.

For procurement specialists and R&D scientists looking to buy Diethyl L-Glutamate Hydrochloride, understanding its applications and sourcing it from a reputable manufacturer is key. The price of such a specialized chemical can vary, but investing in high-purity material from a trusted supplier, such as ourselves, ensures that your development pipeline remains on track. We offer this vital pharmaceutical intermediate for global procurement, supporting your efforts to bring safer and more effective CNS therapies to market. Contact us today to get a quote and learn more about how our product can elevate your drug development projects.